##gff-version 3
O95394	UniProtKB	Chain	1	542	.	.	.	ID=PRO_0000148013;Note=Phosphoacetylglucosamine mutase	
O95394	UniProtKB	Active site	64	64	.	.	.	Note=Phosphoserine intermediate;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:11004509;Dbxref=PMID:11004509	
O95394	UniProtKB	Binding site	64	64	.	.	.	Note=Via phosphate group;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	276	276	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	278	278	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	280	280	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	370	372	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	496	500	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Binding site	505	505	.	.	.	Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9P4V2	
O95394	UniProtKB	Modified residue	1	1	.	.	.	Note=N-acetylmethionine;Ontology_term=ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:19413330,ECO:0007744|PubMed:22223895;Dbxref=PMID:19413330,PMID:22223895	
O95394	UniProtKB	Modified residue	62	62	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0007744;evidence=ECO:0007744|PubMed:24275569;Dbxref=PMID:24275569	
O95394	UniProtKB	Modified residue	64	64	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0007744,ECO:0007744,ECO:0007744,ECO:0007744,ECO:0007744;evidence=ECO:0007744|PubMed:18669648,ECO:0007744|PubMed:19690332,ECO:0007744|PubMed:20068231,ECO:0007744|PubMed:23186163,ECO:0007744|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:23186163,PMID:24275569	
O95394	UniProtKB	Alternative sequence	1	1	.	.	.	ID=VSP_047319;Note=In isoform 3. M->MGGEWGQSAICPESAQEWTYQVGQHLVDM;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O95394	UniProtKB	Alternative sequence	542	542	.	.	.	ID=VSP_047320;Note=In isoform 2. F->YKAAETTHNINNAFGPGTANEHTVP;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95394	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_071359;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity%3B no effect on protein abundance. L->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24698316;Dbxref=dbSNP:rs267608260,PMID:24698316	
O95394	UniProtKB	Natural variant	239	239	.	.	.	ID=VAR_071360;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity. D->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24931394;Dbxref=dbSNP:rs869312886,PMID:24931394	
O95394	UniProtKB	Natural variant	246	246	.	.	.	ID=VAR_071361;Note=In IMD23%3B loss of phosphoacetylglucosamine mutase activity. N->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24931394;Dbxref=dbSNP:rs587777562,PMID:24931394	
O95394	UniProtKB	Natural variant	297	297	.	.	.	ID=VAR_071362;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity%3B decreased protein abundance. D->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24589341;Dbxref=dbSNP:rs587777415,PMID:24589341	
O95394	UniProtKB	Natural variant	340	340	.	.	.	ID=VAR_071363;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity%3B decreased protein abundance. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24698316;Dbxref=PMID:24698316	
O95394	UniProtKB	Natural variant	451	451	.	.	.	ID=VAR_071364;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity. Q->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24931394;Dbxref=dbSNP:rs587777565,PMID:24931394	
O95394	UniProtKB	Natural variant	466	466	.	.	.	ID=VAR_013489;Note=In allele PGM3*2. D->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11004509,ECO:0000269|PubMed:12174217,ECO:0000269|PubMed:15489334;Dbxref=dbSNP:rs473267,PMID:11004509,PMID:12174217,PMID:15489334	
O95394	UniProtKB	Natural variant	501	501	.	.	.	ID=VAR_071365;Note=In IMD23%3B decreased phosphoacetylglucosamine mutase activity%3B no effect on protein abundance. E->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24589341;Dbxref=dbSNP:rs587777413,PMID:24589341	
O95394	UniProtKB	Natural variant	502	502	.	.	.	ID=VAR_071366;Note=In IMD23%3B decreased function in UUDP-N-acetylglucosamine biosynthetic process%3B no effect on protein abundance. D->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24698316;Dbxref=dbSNP:rs267608261,PMID:24698316	
O95394	UniProtKB	Mutagenesis	64	64	.	.	.	Note=Loss of activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11004509;Dbxref=PMID:11004509	
O95394	UniProtKB	Mutagenesis	65	65	.	.	.	Note=Loss of activity. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11004509;Dbxref=PMID:11004509	
O95394	UniProtKB	Mutagenesis	278	278	.	.	.	Note=Loss of activity. D->A%2CE;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11004509;Dbxref=PMID:11004509	
O95394	UniProtKB	Mutagenesis	281	281	.	.	.	Note=Loss of activity. R->A%2CK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11004509;Dbxref=PMID:11004509	
O95394	UniProtKB	Sequence conflict	5	5	.	.	.	Note=A->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95394	UniProtKB	Sequence conflict	70	70	.	.	.	Note=D->G;Ontology_term=ECO:0000305;evidence=ECO:0000305